| dc.contributor.author | GAMDE, Solomon Mathias | |
| dc.contributor.author | FRANCIS, Love | |
| dc.date.accessioned | 2026-07-23T11:15:58Z | |
| dc.date.available | 2026-07-23T11:15:58Z | |
| dc.date.issued | 2024-08 | |
| dc.identifier.other | DOI: 10.47799/pimr.1202.03 | |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/3015 | |
| dc.description.abstract | Immunohistochemistry in cancer diagnosis holds great potenƟal to improve paƟent’s outcomes through enhanced diagnosƟc accuracy and more effecƟve treatment strategies. AnƟgen-anƟbody interacƟons is one of its main objecƟves that uƟlizes the specific binding of anƟbodies to cellular anƟ- gens allowing for the precise idenƟficaƟon and localizaƟon of specific proteins within Ɵssue samples. However, there exist pracƟcal hitches in the form of Ɵssue fixaƟon, epi- tope retrieval, and anƟbody quality. It is crucial to conƟnue streamlining the techniques and scoring systems to guar- antee their reliability in various contexts. Understanding the interactions is pivotal for the accurate diagnosis, prog- nosis, and future perspectives. As technology continues to advance and our understanding of cancer biology deep- ens, immunohistochemistry will remain an invaluable tool for precision in cancer diagnosis. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Perspectves in Medical Research | en_US |
| dc.relation.ispartofseries | Volume 12;No 2 | |
| dc.subject | Principle of Immunohistochemistry | en_US |
| dc.subject | Cancer diagnosis | en_US |
| dc.subject | Diagnostic Biomarkers | en_US |
| dc.title | Immunohistochemistry in Cancer Diagnosis: A Review | en_US |
| dc.type | Article | en_US |